Asundexian versus Apixaban in Patients with Atrial Fibrillation. The New England Journal of Medicine (NEJM) 2025. OCEANIC-AF Steering Committee and Investigators: From Norway John Munkhaugen, Drammen sykehus, MED/NORCOR.